Manage stand orders
Select Option
Guangzhou Leide Biosciences Co.,Ltd
7d, Science & Technology Innovation Base #80 Lanyue Road, Huangpu District,
510623
Guangzhou
China
China
Media files
Contact
Calla Liu
International Marketing Manager
Visit us
16.11.2020
Topic
all-day
17.11.2020
Topic
all-day
18.11.2020
Topic
all-day
19.11.2020
Topic
Our range of products
Product categories
- 03 Diagnostic tests
- 03.02 Immunochemistry testing, immunology testing
- 03.02.01 Immuno assay testing
Immuno assay testing
Our products
Product category: Immuno assay testing
AIMTB ASSAY
AIMTB Assay is used in vitro to measure the specific T cells immune response of Mycobacterium tuberculosis using fresh whole blood
- High sensitivity and specificity
- Only 1.8ml of blood is required, making it's easy to collect
- Unique triple-tube design simplifies the process
- Movable and programmable incubator with a cooling system
- Fast and convenient serum separation column(option), no centrifuge needed
- Automatic ELISA system is highly consistent
- CE,ISO certified
Product category: Immuno assay testing
Rheumatoid Arthritis Citrullinated Protein Diagnostic Kit (ELISA)
Rheumatoid Arthritis Citrullinated Protein Diagnostic Kit（ELISA）is an enzyme immunoassay for the qualitative determination of citrullinated protein in human serum. The result is used as an aid to the diagnosis of Rheumatoid Arthristis (RA) in conjuction with other clinical information.
- New international target for RA diagnosis
- Higher sensitivity than similar products
- Over 50% anti-CCP(-) RA patients can be detected by RA_CP kit
- CE,ISO certified
Product category: Immuno assay testing
SARS-CoV-2 IgG/IgM ELISA kit
SARS-CoV-2 IgG Antibody Diagnostic Kit (ELISA) is an enzyme immunoassay for the qualitative determination of IgG antibodies against SARS-CoV-2 in human serum, and plasma. It is intended for screening of suspected SARS-CoV-2 virus infection patients and as an aid in the diagnosis of the coronavirus disease 2019 (COVID-19).
- ELISA diagnostic kits for SARS-CoV-2 Virus has high sensitivity and specificity
- Easy for sample collecting and sample processing
- Simplifies the manual operation and allows for a fully automatic detection of COVID-19
- Serological markers of COVID-19 by ELISA method have high negative predictive value for screening.Combined with NA-based technology,it can greatly increase the sensitivity of diagnosis while maintaining the high specificity
About us
Company details
Guangzhou Leide Biosciences Co.,Ltd is an innovative in vitro diagnostic company that focuses on DSCIDS- a new generation of in vitro diagnostic technology. DSCIDS breaks through the limitations of existing molecular diagnostic technology and uses cell function analysis to accurately diagnosis complex immune-mediated diseases.
We have professional team in R&D,production and sales. We are headquatered in Guangzhou and having subsidiary companies in the United States (AIMDX).
Our business covers a wide variety fields from infectious diseases,immune function evaluation and immunotherapy for autoimmune diseases to tumors and organ transplants. We have an integrated strategic layout that focuseson the development of in vitro diagnostic reagents, raw materials and special clinical immunoassay services.
We have professional team in R&D,production and sales. We are headquatered in Guangzhou and having subsidiary companies in the United States (AIMDX).
Our business covers a wide variety fields from infectious diseases,immune function evaluation and immunotherapy for autoimmune diseases to tumors and organ transplants. We have an integrated strategic layout that focuseson the development of in vitro diagnostic reagents, raw materials and special clinical immunoassay services.
Company data
Sales volume1-9 Mio US $
Export contentmax. 25%
Number of employees50-99
Foundation2014
Area of businessDiagnostics